javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD8.5138665178123.8894
Domestic EquitiesMAX HEALTHCARE INSTITUTE LTD5.684073245282.7121
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD5.5192128071480.3136
Domestic EquitiesDIVI LABORATORIES LTD5.123111331474.5493
Domestic EquitiesABBOTT INDIA LTD4.97432845372.3844
Domestic EquitiesCIPLA LTD4.771947386169.4396
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD4.61477734567.1509
Domestic EquitiesRAINBOW CHILDRENS MEDICARE LTD4.415545433864.2525
Domestic EquitiesDR REDDYS LABORATORIES LTD4.263845718762.0448
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD4.123424487560.0017
Domestic EquitiesMANKIND PHARMA LTD3.848922001856.0078
Domestic EquitiesFORTIS HEALTHCARE LTD3.349650935148.7423
Domestic EquitiesBAYER CROPSCIENCE LTD3.200011229946.5648
Domestic EquitiesLUPIN LTD2.805716877840.8274
Domestic EquitiesSYNGENE INTERNATIONAL LTD2.731790444939.7505
Domestic EquitiesALKEM LABORATORIES LTD2.64346905838.4653
Domestic EquitiesSAI LIFE SCIENCES LTD2.534529880736.8817
Domestic EquitiesPFIZER LTD2.49968193436.3738
Domestic EquitiesFDC LTD2.344980503834.1215
Domestic EquitiesGLOBAL HEALTH LTD2.316125653233.7032
Domestic EquitiesPROCTER & GAMBLE HEALTH LTD1.78834113226.0222
Domestic EquitiesCONCORD BIOTECH LTD1.761020017125.6259
Domestic EquitiesDR. LAL PATH LABS LTD1.640914505123.8783
Domestic EquitiesNEULAND LABORATORIES LTD1.60211254823.3129
Domestic EquitiesAJANTA PHARMA LTD1.60076805223.2922
Domestic EquitiesSANOFI INDIA LTD1.52786526822.2322
Domestic EquitiesMETROPOLIS HEALTHCARE LTD1.453939167321.1562
Domestic EquitiesGILLETTE INDIA LTD1.22912329017.8856
Domestic EquitiesTORRENT PHARMACEUTICALS LTD1.01873208614.8241
Domestic EquitiesSUMITOMO CHEMICAL INDIA LTD0.970933571014.1284
Domestic EquitiesJUBILANT PHARMOVA LTD0.908313613613.2174
Domestic EquitiesDR. AGARWALS HEALTH CARE LTD0.60121826718.7490
Domestic EquitiesIPCA LABORATORIES LTD0.5845500008.5050
Domestic EquitiesZIM LABORATORIES LTD0.48715716297.0882
Total 97.4526 1418.0942
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET2.3084 33.5909
Cash & Cash Equivalents and Net AssetsF) REPO0.2390 3.4774
Total 2.5474 37.0683
 
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.